Nikola P. Pavletich - Publications

Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States 
Cancer Biology, Structural Biology

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Yang H, Jiang X, Li B, Yang HJ, Miller M, Yang A, Dhar A, Pavletich NP. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature. PMID 29236692 DOI: 10.1038/nature25023  0.68
2016 Chang E, Pourmal S, Zhou C, Kumar R, Teplova M, Pavletich NP, Marians KJ, Erdjument-Bromage H. N-Terminal Amino Acid Sequence Determination of Proteins by N-Terminal Dimethyl Labeling: Pitfalls and Advantages When Compared with Edman Degradation Sequence Analysis. Journal of Biomolecular Techniques : Jbt. PMID 27006647 DOI: 10.7171/jbt.16-2702-002  0.96
2015 Zhou C, Pourmal S, Pavletich NP. Dna2 nuclease-helicase structure, mechanism and regulation by Rpa. Elife. 4. PMID 26491943 DOI: 10.7554/eLife.09832  0.92
2014 Wang R, Persky NS, Yoo B, Ouerfelli O, Smogorzewska A, Elledge SJ, Pavletich NP. Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1 Science. 346: 1127-1130. DOI: 10.1126/science.1258973  0.92
2013 Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP. MTOR kinase structure, mechanism and regulation Nature. 497: 217-223. PMID 23636326 DOI: 10.1038/nature12122  0.92
2012 Fan J, Pavletich NP. Structure and conformational change of a replication protein A heterotrimer bound to ssDNA Genes and Development. 26: 2337-2347. PMID 23070815 DOI: 10.1101/gad.194787.112  0.92
2011 Joo W, Xu G, Persky NS, Smogorzewska A, Rudge DG, Buzovetsky O, Elledge SJ, Pavletich NP. Structure of the FANCI-FANCD2 complex: Insights into the Fanconi anemia DNA repair pathway Science. 333: 312-316. PMID 21764741 DOI: 10.1126/science.1205805  0.92
2010 Takai H, Xie Y, de Lange T, Pavletich NP. Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. Genes & Development. 24: 2019-30. PMID 20801936 DOI: 10.1101/gad.1956410  0.92
2009 Cai Z, Chehab NH, Pavletich NP. Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase Molecular Cell. 35: 818-829. PMID 19782031 DOI: 10.1016/j.molcel.2009.09.007  0.92
2008 Scrima A, Koníčková R, Czyzewski BK, Kawasaki Y, Jeffrey PD, Groisman R, Nakatani Y, Iwai S, Pavletich NP, Thomä NH. Structural Basis of UV DNA-Damage Recognition by the DDB1-DDB2 Complex Cell. 135: 1213-1223. PMID 19109893 DOI: 10.1016/j.cell.2008.10.045  0.92
2008 Chen Z, Yang H, Pavletich NP. Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures Nature. 453: 489-494. PMID 18497818 DOI: 10.1038/nature06971  0.92
2007 Min JH, Pavletich NP. Recognition of DNA damage by the Rad4 nucleotide excision repair protein Nature. 449: 570-575. PMID 17882165 DOI: 10.1038/nature06155  0.92
2007 Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. Structure of a Fbw7-Skp1-Cyclin E Complex: Multisite-Phosphorylated Substrate Recognition by SCF Ubiquitin Ligases Molecular Cell. 26: 131-143. PMID 17434132 DOI: 10.1016/j.molcel.2007.02.022  0.92
2007 Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, et al. Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression Cell. 128: 141-156. PMID 17218261 DOI: 10.1016/j.cell.2006.11.040  0.92
2007 Poyurovsky MV, Priest C, Kentsis A, Borden KLB, Pan ZQ, Pavletich N, Prives C. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity Embo Journal. 26: 90-101. PMID 17170710 DOI: 10.1038/sj.emboj.7601465  0.92
2007 Zheng N, Pavletich NP. The Structural Biology of Ubiquitin-Protein Ligases Protein Degradation. 1: 156-189. DOI: 10.1002/9783527619320.ch7  0.96
2005 Rubin SM, Gall AL, Zheng N, Pavletich NP. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell. 123: 1093-106. PMID 16360038 DOI: 10.1016/j.cell.2005.09.044  0.92
2005 Li T, Pavletich NP, Schulman BA, Zheng N. High-level expression and purification of recombinant SCF ubiquitin ligases Methods in Enzymology. 398: 125-142. PMID 16275325 DOI: 10.1016/S0076-6879(05)98012-9  0.92
2005 Hao B, Zheng N, Schulman BA, Wu G, Miller JJ, Pagano M, Pavletich NP. Structural basis of the Cks1-dependent recognition of p27 Kip1 by the SCF Skp2 ubiquitin ligase Molecular Cell. 20: 9-19. PMID 16209941 DOI: 10.1016/j.molcel.2005.09.003  0.92
2005 Thomä NH, Czyzewski BK, Alexeev AA, Mazin AV, Kowalczykowski SC, Pavletich NP. Structure of the SWI2/SNF2 chromatin-remodeling domain of eukaryotic Rad54 Nature Structural and Molecular Biology. 12: 350-356. PMID 15806108 DOI: 10.1038/nsmb919  0.92
2005 Yang H, Li Q, Fan J, Holloman WK, Pavletich NP. The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction. Nature. 433: 653-7. PMID 15703751 DOI: 10.1038/nature03234  0.92
2004 Huyen Y, Jeffrey PD, Derry WB, Rothman JH, Pavletich NP, Stavridi ES, Halazonetis TD. Structural differences in the DNA binding domains of human p53 and its C. elegans ortholog Cep-1. Structure (London, England : 1993). 12: 1237-43. PMID 15242600 DOI: 10.1016/j.str.2004.05.007  0.92
2004 Misra RN, Xiao HY, Kim KS, Lu S, Han WC, Barbosa SA, Hunt JT, Rawlins DB, Shan W, Ahmed SZ, Qian L, Chen BC, Zhao R, Bednarz MS, Kellar KA, ... ... Pavletich NP, et al. N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. Journal of Medicinal Chemistry. 47: 1719-28. PMID 15027863 DOI: 10.1021/jm0305568  0.92
2003 Kojic M, Yang H, Kostrub CF, Pavletich NP, Holloman WK. The BRCA2-interacting protein DSS1 is vital for DNA repair, recombination, and genome stability in Ustilago maydis. Molecular Cell. 12: 1043-9. PMID 14580353 DOI: 10.1016/S1097-2765(03)00367-8  0.92
2003 Von Kobbe C, Thomäs NH, Czyzewski BK, Pavletich NP, Bohr VA. Werner Syndrome Protein Contains Three Structure-specific DNA Binding Domains Journal of Biological Chemistry. 278: 52997-53006. PMID 14534320 DOI: 10.1074/jbc.M308338200  0.92
2003 Stavridi ES, Harris KG, Huyen Y, Bothos J, Verwoerd PM, Stayrook SE, Pavletich NP, Jeffrey PD, Luca FC. Crystal structure of a human Mob1 protein: Toward understanding Mob-regulated cell cycle pathways Structure. 11: 1163-1170. PMID 12962634 DOI: 10.1016/S0969-2126(03)00182-5  0.92
2003 Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW, Pavletich NP. Structure of a β-TrCP1-Skp1-β-catenin complex: Destruction motif binding and lysine specificity of the SCFβ-TrCP1 ubiquitin ligase Molecular Cell. 11: 1445-1456. PMID 12820959 DOI: 10.1016/S1097-2765(03)00234-X  0.92
2003 Chai J, Wu JW, Yan N, Massagué J, Pavletich NP, Shi Y. Features of a Smad3 MH1-DNA complex: Roles of water and zinc in DNA binding Journal of Biological Chemistry. 278: 20327-20331. PMID 12686552 DOI: 10.1074/jbc.C300134200  0.92
2002 Pavletich NP. Structural biology of ubiquitin-protein ligases. Harvey Lectures. 98: 65-102. PMID 16033158  0.92
2002 Nowakowski J, Cronin CN, McRee DE, Knuth MW, Nelson CG, Pavletich NP, Rogers J, Sang BC, Scheibe DN, Swanson RV, Thompson DA. Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography Structure. 10: 1659-1667. PMID 12467573 DOI: 10.1016/S0969-2126(02)00907-3  0.92
2002 Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thomä NH, Zheng N, Chen PL, Lee WH, Pavletich NP. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure Science. 297: 1837-1848. PMID 12228710 DOI: 10.1126/science.297.5588.1837  0.92
2002 Kim KS, Kimball SD, Misra RN, Rawlins DB, Hunt JT, Xiao HY, Lu S, Qian L, Han WC, Shan W, Mitt T, Cai ZW, Poss MA, Zhu H, Sack JS, ... ... Pavletich N, et al. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities. Journal of Medicinal Chemistry. 45: 3905-27. PMID 12190313 DOI: 10.1021/jm0201520  0.92
2002 Stavridi ES, Huyen Y, Loreto IR, Scolnick DM, Halazonetis TD, Pavletich NP, Jeffrey PD. Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate Structure. 10: 891-899. PMID 12121644 DOI: 10.1016/S0969-2126(02)00776-1  0.92
2002 Min JH, Yang H, Ivan M, Gertler F, Kaelin WG, Pavletich NP. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science (New York, N.Y.). 296: 1886-9. PMID 12004076 DOI: 10.1126/science.1073440  0.36
2002 Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, Koepp DM, Elledge SJ, Pagano M, Conaway RC, Conaway JW, Harper JW, Pavletich NP. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex Nature. 416: 703-709. PMID 11961546 DOI: 10.1038/416703a  0.92
2002 Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure Genes and Development. 16: 583-593. PMID 11877378 DOI: 10.1101/gad.959202  0.92
2001 Finnin MS, Donigian JR, Pavletich NP. Structure of the histone deacetylase SIRT2 Nature Structural Biology. 8: 621-625. PMID 11427894 DOI: 10.1038/89668  0.92
2001 Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, Pagano M. Role of the F-box protein Skp2 in lymphomagenesis Proceedings of the National Academy of Sciences of the United States of America. 98: 2515-2520. PMID 11226270 DOI: 10.1073/pnas.041475098  0.92
2001 Hagopian JC, Kirtley MP, Stevenson LM, Gergis RM, Russo AA, Pavletich NP, Parsons SM, Lew J. Kinetic basis for activation of CDK2/cyclin A by phosphorylation. The Journal of Biological Chemistry. 276: 275-80. PMID 11029468 DOI: 10.1074/jbc.M007337200  0.92
2000 Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP, Hanafusa H. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Research. 60: 7033-8. PMID 11156408  0.92
2000 Jeffrey PD, Tong L, Pavletich NP. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors Genes and Development. 14: 3115-3125. PMID 11124804 DOI: 10.1101/gad.851100  0.92
2000 Schulman BA, Carrano AC, Jeffrey PD, Bowen Z, Kinnucan ERE, Finnin MS, Elledge SJ, Harper JW, Pagano M, Pavletich NP. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex Nature. 408: 381-386. PMID 11099048 DOI: 10.1038/35042620  0.92
2000 Zheng N, Wang P, Jeffrey PD, Pavletich NP. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases Cell. 102: 533-539. PMID 10966114  0.92
2000 Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nature Cell Biology. 2: 423-7. PMID 10878807 DOI: 10.1038/35017054  0.92
2000 Jin S, Martinek S, Joo WS, Wortman JR, Mirkovic N, Sali A, Yandell MD, Pavletich NP, Young MW, Levine AJ. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proceedings of the National Academy of Sciences of the United States of America. 97: 7301-6. PMID 10860994 DOI: 10.1073/pnas.97.13.7301  0.92
1999 Ohh M, Takagi Y, Aso T, Stebbins CE, Pavletich NP, Zbar B, Conaway RC, Conaway JW, Kaelin WG. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein Journal of Clinical Investigation. 104: 1583-1591. PMID 10587522  0.92
1999 Huang L, Kinnucan E, Wang G, Beaudenon S, Howley PM, Huibregtse JM, Pavletich NP. Structure of an E6AP-UbcH7 complex: Insights into ubiquitination by the E2-E3 enzyme cascade Science. 286: 1321-1326. PMID 10558980 DOI: 10.1126/science.286.5443.1321  0.92
1999 Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell. 99: 323-34. PMID 10555148 DOI: 10.1016/S0092-8674(00)81663-3  0.92
1999 Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors Nature. 401: 188-193. PMID 10490031 DOI: 10.1038/43710  0.92
1999 Byrd CA, Bornmann W, Erdjument-Bromage H, Tempst P, Pavletich N, Rosen N, Nathan CF, Ding A. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America. 96: 5645-50. PMID 10318938 DOI: 10.1073/pnas.96.10.5645  0.92
1999 Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors Journal of Molecular Biology. 287: 821-828. PMID 10222191 DOI: 10.1006/jmbi.1999.2640  0.92
1999 Stebbins CE, Kaelin WG, Pavletich NP. Structure of the VHL-elonginC-elonginB complex: Implications for VHL tumor suppressor function Science. 284: 455-461. PMID 10205047 DOI: 10.1126/science.284.5413.455  0.92
1999 Zheng N, Fraenkel E, Pabo CO, Pavletich NP. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes & Development. 13: 666-74. PMID 10090723  0.92
1998 Obermann WM, Sondermann H, Russo AA, Pavletich NP, Hartl FU. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. The Journal of Cell Biology. 143: 901-10. PMID 9817749 DOI: 10.1083/jcb.143.4.901  0.92
1998 Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 395: 237-43. PMID 9751050 DOI: 10.1038/26155  0.92
1998 Shi Y, Wang YF, Jayaraman L, Yang H, Massagué J, Pavletich NP. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-β signaling Cell. 94: 585-594. PMID 9741623 DOI: 10.1016/S0092-8674(00)81600-1  0.92
1998 Kaldis P, Russo AA, Chou HS, Pavletich NP, Solomon MJ. Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Molecular Biology of the Cell. 9: 2545-60. PMID 9725911  0.92
1998 Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massagué J. Determinants of specificity in TGF-β signal transduction Genes and Development. 12: 2144-2152. PMID 9679059  0.92
1998 Cheng C, Kussie P, Pavletich N, Shuman S. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases Cell. 92: 841-850. PMID 9529259 DOI: 10.1016/S0092-8674(00)81411-7  0.92
1998 Brachmann RK, Yu K, Eby Y, Pavletich NP, Boeke JD. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations Embo Journal. 17: 1847-1859. PMID 9524109 DOI: 10.1093/emboj/17.7.1847  0.92
1998 Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature. 391: 859-65. PMID 9495340 DOI: 10.1038/36038  0.92
1998 Lo RS, Chen YG, Shi Y, Pavletich NP, Massagué J. The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-β receptors Embo Journal. 17: 996-1005. PMID 9463378 DOI: 10.1093/emboj/17.4.996  0.92
1997 Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4 Nature. 388: 87-93. PMID 9214508 DOI: 10.1038/40431  0.92
1997 Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 89: 239-50. PMID 9108479  0.92
1997 Collins K, Jacks T, Pavletich NP. The cell cycle and cancer Proceedings of the National Academy of Sciences of the United States of America. 94: 2776-2778. PMID 9096291 DOI: 10.1073/pnas.94.7.2776  0.92
1996 Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science. 274: 948-953. PMID 8875929 DOI: 10.1126/science.274.5289.948  0.92
1996 Gorina S, Pavletich NP. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2 Science. 274: 1001-1005. PMID 8875926 DOI: 10.1126/science.274.5289.1001  0.92
1996 Russo AA, Jeffrey PD, Pavletich NP. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature Structural Biology. 3: 696-700. PMID 8756328 DOI: 10.1038/nsb0896-696  0.92
1996 Russo AA, Jeffrey PD, Patten AK, Massagué J, Pavletich NP. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature. 382: 325-31. PMID 8684460 DOI: 10.1038/382325a0  0.92
1995 Jeffrey PD, Gorina S, Pavletich NP. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms Science. 267: 1498-1502. PMID 7878469  0.92
1995 Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massagué J, Pavletich NP. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376: 313-20. PMID 7630397 DOI: 10.1038/376313a0  0.92
1995 Wu L, Henri Bayle J, Elenbaas B, Pavletich NP, Levine AJ. Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids Molecular and Cellular Biology. 15: 497-504. PMID 7528329  0.92
1994 Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations Science. 265: 346-355. PMID 8023157  0.92
1994 Prives C, Bargonetti J, Farmer G, Ferrari E, Friedlander P, Wang Y, Jayaraman L, Pavletich N, Hubscher U. DNA-binding properties of the p53 tumor suppressor protein Cold Spring Harbor Symposia On Quantitative Biology. 59: 207-213. PMID 7587071  0.92
1993 Pavletich NP, Pabo CO. Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science (New York, N.Y.). 261: 1701-7. PMID 8378770  0.92
1993 Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes & Development. 7: 2556-64. PMID 8276238  0.92
1991 Pavletich NP, Pabo CO. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science (New York, N.Y.). 252: 809-17. PMID 2028256  0.92
Show low-probability matches.